China’s Wegovy approval for MASH strengthens Novo Nordisk’s global position, extending the GLP-1 drug’s reach from weight management into liver disease.
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Jayakumar A V, President (Quality), Ajanta Pharma Ltd, discusses how pharmaceutical manufacturers can turn deviation management from a compliance exercise into a strategic
BMS’s third CAR-T bet pays off as arlo-cel shows meaningful response gains in heavily pretreated multiple myeloma patients.
Sun Pharma wins investment-grade ratings as its USD 11.75-billion Organon deal strengthens scale, geographic reach and growth opportunities.
India’s Pharma Manufacturing boom needs more Women in Core Plant Operations to build skilled talent, improve inclusion and support the industry’s global growth.
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Aurelien Breton, Managing Director, Servier India, discusses what it will take for India to move beyond making innovative therapies available to making them meaningfully a
Medicine overpricing in India has triggered a dispute as drug companies challenge the NPPA’s proposal to shift sole accountability onto manufacturers.
VitSupp, a science-first wellness brand that aims to simplify nutrition, has announced the launch of its first product: a clean-label, high-absorption Vegan Vitamin D3 + K2 supplement, specifically created
GSK is pushing its flu vaccine candidate into a crucial late-stage trial. The company plans to start a Phase III trial in September 2026. The move follows positive Phase II results for its mRNA flu vaccine candidate. The vaccine produced stronger...
Aurobindo Pharma has marked a major milestone as its US subsidiary, Lannett Company LLC, launched the generic version of Advair Diskus in the American market on 31 August 2026
.jpg)
, CDSCO.jpg)
